Streptokinase biosimilar - Sedico

Drug Profile

Streptokinase biosimilar - Sedico

Alternative Names: Sedonase

Latest Information Update: 03 Mar 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Sedico
  • Class Coenzymes; Plasminogen activator enzymes; Thrombolytics
  • Mechanism of Action Fibrinolytic agents; Plasmin stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Central retinal vein occlusion; Deep vein thrombosis; Myocardial infarction; Peripheral arterial occlusive disorders; Pulmonary embolism

Most Recent Events

  • 03 Mar 2014 Launched prior to March 2013 for Deep vein thrombosis in Egypt (IV)
  • 03 Mar 2014 Launched prior to March 2013 for Pulmonary embolism in Egypt (IV)
  • 03 Mar 2014 Launched prior to March 2013 for Central retinal vein occlusion in Egypt (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top